Research on mapping diabetes-susceptibility genes is dependent on several factors, including the existence of a single major gene for susceptibility, genetic homogeneity, and the existence of appropriate clinical material. The power to detect susceptibility genes is dependent on the risks in relatives and the distance of genetic markers from the susceptibility genes. For insulin-dependent diabetes mellitus (IDDM), the bestfitting risk models are those with a single major locus with residual polygenic factors. The major locus effect is likely represented by genes in the HLA complex, because specific genotypes have been found to affect IDDM risk significantly. Thus, mapping the remaining polygenic IDDM susceptibility factors—each of small effect—is a difficult and long task. For non-insulindependent diabetes mellitus (NIDDM), the likely risk models result in few genes with moderate effect. Models of NIDDM have significant residual polygenic variation remaining, reflecting the importance of multiple loci with small effect, environmental effects, or genetic heterogeneity; however, the prospects for mapping genes that provide at least moderate susceptibility for NIDDM now appear promising.
Skip Nav Destination
Article navigation
Perspectives in Diabetes|
November 01 1990
Mapping Genes in Diabetes: Genetic Epidemiological Perspective
Stephen S Rich
Stephen S Rich
Department of Laboratory Medicine and Pathology and the Institute of Human Genetics, University of Minnesota
Minneapolis, Minnesota
Search for other works by this author on:
Address correspondence and reprint requests to Dr. Stephen S. Rich, Box 511 UMHC, 420 Delaware Street, SE, Minneapolis, MN 55455.
Diabetes 1990;39(11):1315–1319
Article history
Received:
July 09 1990
Accepted:
July 11 1990
PubMed:
2227105
Citation
Stephen S Rich; Mapping Genes in Diabetes: Genetic Epidemiological Perspective. Diabetes 1 November 1990; 39 (11): 1315–1319. https://doi.org/10.2337/diab.39.11.1315
Download citation file:
580
Views